1. Home
  2. PZZA vs TRVI Comparison

PZZA vs TRVI Comparison

Compare PZZA & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Papa John's International Inc.

PZZA

Papa John's International Inc.

HOLD

Current Price

$32.60

Market Cap

1.2B

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$14.21

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PZZA
TRVI
Founded
1984
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
PZZA
TRVI
Price
$32.60
$14.21
Analyst Decision
Buy
Strong Buy
Analyst Count
8
11
Target Price
$45.00
$21.55
AVG Volume (30 Days)
1.1M
916.5K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
5.25%
N/A
EPS Growth
N/A
31.91
EPS
0.21
N/A
Revenue
$2,068,421,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$154.00
N/A
Revenue Growth
14.07
N/A
52 Week Low
$30.16
$5.41
52 Week High
$55.74
$16.12

Technical Indicators

Market Signals
Indicator
PZZA
TRVI
Relative Strength Index (RSI) 48.04 56.04
Support Level $30.73 $10.07
Resistance Level $35.36 $14.57
Average True Range (ATR) 1.40 0.58
MACD 0.03 -0.03
Stochastic Oscillator 45.68 80.34

Price Performance

Historical Comparison
PZZA
TRVI

About PZZA Papa John's International Inc.

Papa John's International Inc operates and franchises pizza delivery and carryout restaurants and, in certain international markets, dine-in and delivery restaurants. It has four defined reportable segments: Domestic Company-owned restaurants, North America franchising, North America commissaries, and International. The company derives maximum revenue from North America commissaries segment. The North America commissaries segment consists of the operations of its regional dough production and product distribution centers in the United States and Canada and derives its revenues principally from the sale and distribution of food and paper products to Domestic Company-owned and franchised restaurants in the United States and Canada.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Share on Social Networks: